Related Experiment Video
Updated: Jan 11, 2026
Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
Synthesis of Psidium meroterpenoids with anti-hepatocellular carcinoma activities
1Southern University of Science and Technology, School of Medicine, Shenzhen 518055, People's Republic of China.
Abstract:
Liver cancer presents as a significant human disease, and hepatocellular carcinoma appears as the most common form of liver cancer. Several therapeutic agents, such as sorafenib, are currently in Phase III clinical trials for the treatment of liver cancer. However, the development of potent and effective pharmaceuticals is undoubtedly crucial to managing the status of liver cancer and improving the quality of life of patients. Psidium meroterpenoids are natural products isolated from the leaves of Psidium guajava L., exhibiting potent cytotoxicity to hepatocellular carcinoma cell lines. Being synthetically accessible, Psidium meroterpenoids show tremendous potential as a therapeutic agent for hepatocellular carcinoma. This perspective outlines the biological profile, biosynthetic pathway, and chemical synthesis of Psidium meroterpenoids, as well as future directions and opportunities.
Insights
Psidium meroterpenoids, natural compounds from Psidium guajava L., show strong cytotoxicity against liver cancer cells. These synthetically accessible compounds offer promising therapeutic potential for hepatocellular carcinoma treatment.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Oncology
Background:
- Hepatocellular carcinoma (HCC) is the most common type of liver cancer.
- Current treatments like sorafenib are in clinical trials, but new effective drugs are needed.
- Natural products offer a source of novel therapeutic agents.
Purpose of the Study:
- To review the biological profile, biosynthesis, and synthesis of Psidium meroterpenoids.
- To highlight the therapeutic potential of Psidium meroterpenoids for hepatocellular carcinoma.
- To discuss future research directions and opportunities.
Main Methods:
- Literature review of Psidium meroterpenoids.
- Analysis of cytotoxicity data against HCC cell lines.
- Overview of synthetic accessibility and biosynthetic pathways.
Main Results:
- Psidium meroterpenoids exhibit potent cytotoxicity against hepatocellular carcinoma cell lines.
- These compounds are derived from Psidium guajava L. leaves.
- Psidium meroterpenoids are synthetically accessible, facilitating drug development.
Conclusions:
- Psidium meroterpenoids represent a promising class of natural products for HCC therapy.
- Further research into their biological activity and synthetic optimization is warranted.
- These compounds could lead to novel treatments for liver cancer, improving patient outcomes.
More Related Videos
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023